Xenon Pharmaceuticals Inc (XENE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for XENE. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR LLC | 10,818,491 | $629M | INCREASED |
| Avoro Capital Advisors LLC | 5,777,777 | $336M | INCREASED |
| BlackRock, Inc. | 5,640,118 | $328M | INCREASED |
| WELLINGTON MANAGEMENT GROUP LLP | 4,829,641 | $281M | INCREASED |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,491,653 | $261M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Gillian Cannon (Director) | SELL | 1,190 | $63K | 2026-06-05 |
| Gary Patou (Director) | SELL | 1,322 | $70K | 2026-06-05 |
| Dawn Svoronos (Director) | AWARD | 1,593 | 2026-06-01 | |
| Dawn Svoronos (Director) | AWARD | 10,507 | $562K | 2026-06-01 |
| Dawn Svoronos (Director) | SELL | 1,416 | $76K | 2026-06-01 |
Full institutional holdings, insider history, and congressional trades for Xenon Pharmaceuticals Inc on SentiSense.